NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.

MLA

Coutinho, Leandro L., et al. “NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.” International Journal of Molecular Sciences, vol. 25, no. 11, June 2024, p. 6103. EBSCOhost, https://doi.org/10.3390/ijms25116103.

APA

Coutinho, L. L., Femino, E. L., Gonzalez, A. L., Moffat, R. L., Heinz, W. F., Cheng, R. Y. S., Lockett, S. J., Rangel, M. C., Ridnour, L. A., & Wink, D. A. (2024). NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer. International Journal of Molecular Sciences, 25(11), 6103. https://doi.org/10.3390/ijms25116103

Chicago

Coutinho, Leandro L., Elise L. Femino, Ana L. Gonzalez, Rebecca L. Moffat, William F. Heinz, Robert Y. S. Cheng, Stephen J. Lockett, M. Cristina Rangel, Lisa A. Ridnour, and David A. Wink. 2024. “NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.” International Journal of Molecular Sciences 25 (11): 6103. doi:10.3390/ijms25116103.